HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 194 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $609,000 | -3.8% | 14,265 | -39.6% | 0.05% | -24.6% |
| Q2 2020 | $633,000 | -83.9% | 23,622 | -89.3% | 0.06% | -45.4% |
| Q4 2019 | $3,928,000 | +1529.9% | 221,558 | +1565.8% | 0.12% | +1387.5% |
| Q3 2018 | $241,000 | -74.5% | 13,300 | -72.5% | 0.01% | -50.0% |
| Q1 2018 | $946,000 | -66.2% | 48,300 | -65.0% | 0.02% | -61.0% |
| Q4 2017 | $2,797,000 | +732.4% | 138,100 | +305.0% | 0.04% | +412.5% |
| Q4 2016 | $336,000 | +1.2% | 34,100 | +24.0% | 0.01% | -27.3% |
| Q3 2016 | $332,000 | -34.4% | 27,500 | -53.2% | 0.01% | -54.2% |
| Q2 2016 | $506,000 | -10.0% | 58,700 | -1.2% | 0.02% | -11.1% |
| Q1 2016 | $562,000 | +15.2% | 59,400 | +63.2% | 0.03% | -27.0% |
| Q3 2015 | $488,000 | +82.1% | 36,400 | +93.6% | 0.04% | +42.3% |
| Q1 2015 | $268,000 | +49.7% | 18,800 | +1.1% | 0.03% | -7.1% |
| Q4 2014 | $179,000 | – | 18,600 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |